SCHEMBL13655125

SCHEMBL13655125

C#CCCC(O)CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28655425 1.00
SCHEMBL10616236 0.86 USP2 (0.55)
SCHEMBL5606111 0.83 FFAR4 (0.48)
SCHEMBL5606115 0.83 FFAR4 (0.48)
SCHEMBL3909824 0.83 USP2 (0.42)
SCHEMBL10052022 0.81
SCHEMBL17231293 0.81
SCHEMBL19331620 0.81
SCHEMBL813851 0.80 FDPS (0.31)
SCHEMBL22249 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116419-B Treprostinil intermediate and preparation process thereof 江苏豪森药业集团有限公司 2022-03-29 CN disclosed
CN-113754623-A Preparation method of treprostinil intermediate 上海京河医药科技有限公司 2021-12-07 CN disclosed
EP-1971601-B1 N4-PHENYL-QUINAZOLINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES ARRAY BIOPHARMA INC (US) 2009-10-21 EP disclosed